Keywords: tysabri, crohn, disease, sbla, submitted, fda, irish

Tysabri for Crohn's disease sBLA submitted to FDA

Article | 22 December 2006

Print This

Irish biotechnology company Elan and USA-based pharmaceutical firm Biogen Idec say that they have completed the submission of a supplemental ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in